| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |